Page last updated: 2024-10-30

mesalamine and Angiomatosis

mesalamine has been researched along with Angiomatosis in 1 studies

Mesalamine: An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)
mesalamine : A monohydroxybenzoic acid that is salicylic acid substituted by an amino group at the 5-position.

Angiomatosis: A condition with multiple tumor-like lesions caused either by congenital or developmental malformations of BLOOD VESSELS, or reactive vascular proliferations, such as in bacillary angiomatosis. Angiomatosis is considered non-neoplastic.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Stiefelhagen, P1

Other Studies

1 other study available for mesalamine and Angiomatosis

ArticleYear
["Treatment refractory" ulcerative colitis].
    MMW Fortschritte der Medizin, 2007, Feb-15, Volume: 149, Issue:7

    Topics: Adrenal Cortex Hormones; Adult; Angiography; Angiomatosis; Biopsy; Colitis, Ischemic; Colitis, Ulcer

2007